CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 175 filers reported holding CARA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $64,979 | -53.0% | 13,234 | +2.7% | 0.00% | 0.0% |
| Q4 2022 | $138,396 | +19.3% | 12,886 | +4.1% | 0.00% | 0.0% |
| Q3 2022 | $116,000 | +4.5% | 12,379 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $111,000 | -20.7% | 12,209 | +5.6% | 0.00% | 0.0% |
| Q1 2022 | $140,000 | +6.9% | 11,561 | +7.2% | 0.00% | 0.0% |
| Q4 2021 | $131,000 | -22.5% | 10,785 | -1.1% | 0.00% | 0.0% |
| Q3 2021 | $169,000 | +9.0% | 10,907 | +0.6% | 0.00% | 0.0% |
| Q2 2021 | $155,000 | -48.2% | 10,846 | -21.3% | 0.00% | -66.7% |
| Q1 2021 | $299,000 | +53.3% | 13,781 | +6.8% | 0.00% | +50.0% |
| Q4 2020 | $195,000 | +14.0% | 12,908 | -3.8% | 0.00% | 0.0% |
| Q3 2020 | $171,000 | 0.0% | 13,414 | +34.0% | 0.00% | 0.0% |
| Q2 2020 | $171,000 | – | 10,009 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,193,057 | $51,440,000 | 39.10% |
| Chescapmanager LLC | 1,299,701 | $20,938,000 | 3.08% |
| Burrage Capital Management LLC | 284,170 | $4,578,000 | 3.07% |
| Cypress Capital Management LLC (WY) | 184,085 | $2,966,000 | 2.80% |
| DAFNA Capital Management LLC | 328,533 | $5,293,000 | 1.82% |
| Mesirow Financial Investment Management, Inc. | 21,169 | $341,000 | 1.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 471,575 | $7,597,000 | 1.14% |
| AdvisorShares Investments LLC | 79,821 | $1,286,000 | 0.80% |
| ETF MANAGERS GROUP, LLC | 750,680 | $12,093,000 | 0.42% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,300,000 | $37,053,000 | 0.25% |